Quick Takeaways
- Prosight Management, LP filed SCHEDULE 13G/A for ADC Therapeutics SA Common Shares (ADCT).
- Disclosed ownership: 5.8%.
- Date of event: 30 Sep 2025.
Prosight Management, LP - 30 Sep 2025 SCHEDULE 13G/A Report for ADC Therapeutics SA Common Shares (ADCT)
- Filing Manager
- Prosight Management, LP
- Reporting Manager
- Prosight Management, LP
- Security
- ADC Therapeutics SA Common Shares
- Symbol
- ADCT
- Shares outstanding
- 124,058,172 shares
- Disclosed Ownership
- 7,195,374 shares
- Ownership
- 5.8%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 Nov 2025, 19:38:57 UTC
- Date of event
- 30 Sep 2025
- Next filing
- 13 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Prosight Management, LP disclosed 5.8% ownership in ADC Therapeutics SA Common Shares (ADCT) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Nov 2025, 19:38.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (5)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Prosight Management, LP | 5.8% | 7,195,374 | 0 | 7,195,374 | Prosight Partners, LLC | General Partner | |
| Prosight Fund, LP | 0.3% | 350,415 | 0 | 350,415 | Prosight Management, LP | General Partner | |
| Prosight Plus Fund, LP | 1.3% | 1,586,895 | 0 | 1,586,895 | Prosight Management, LP | General Partner | |
| Prosight Partners, LLC | 5.8% | 7,195,374 | 0 | 7,195,374 | /s/ W. Lawrence Hawkins | Sole Manager | |
| W. Lawrence Hawkins | 5.8% | 7,195,374 | 0 | 7,195,374 | /s/ W. Lawrence Hawkins | W. Lawrence Hawkins |